Frankel, Amylynne, M.D. Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2010
NCT01228409
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now